267 related articles for article (PubMed ID: 24185179)
1. Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells.
Sato A; Okada M; Shibuya K; Watanabe E; Seino S; Narita Y; Shibui S; Kayama T; Kitanaka C
Stem Cell Res; 2014 Jan; 12(1):119-31. PubMed ID: 24185179
[TBL] [Abstract][Full Text] [Related]
2. Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK.
Sato A; Sunayama J; Okada M; Watanabe E; Seino S; Shibuya K; Suzuki K; Narita Y; Shibui S; Kayama T; Kitanaka C
Stem Cells Transl Med; 2012 Nov; 1(11):811-24. PubMed ID: 23197693
[TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells.
Ito K; Hirao A; Arai F; Takubo K; Matsuoka S; Miyamoto K; Ohmura M; Naka K; Hosokawa K; Ikeda Y; Suda T
Nat Med; 2006 Apr; 12(4):446-51. PubMed ID: 16565722
[TBL] [Abstract][Full Text] [Related]
4. Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanism.
Yuan S; Lu Y; Yang J; Chen G; Kim S; Feng L; Ogasawara M; Hammoudi N; Lu W; Zhang H; Liu J; Colman H; Lee JS; Li XN; Xu RH; Huang P; Wang F
Stem Cell Res Ther; 2015 Oct; 6():198. PubMed ID: 26472041
[TBL] [Abstract][Full Text] [Related]
5. Juglone induces apoptosis of tumor stem-like cells through ROS-p38 pathway in glioblastoma.
Wu J; Zhang H; Xu Y; Zhang J; Zhu W; Zhang Y; Chen L; Hua W; Mao Y
BMC Neurol; 2017 Apr; 17(1):70. PubMed ID: 28388894
[TBL] [Abstract][Full Text] [Related]
6. [The relationship between reactive oxygen species-dependent activation of p38 MAPK and the expression of tumor necrosis factor-α in cultured cardiomyocytes].
Shang FJ; Wang JP; Zheng QS; Liu XT; Xue YS; Li J; Zhao LY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jan; 27(1):7-10. PubMed ID: 21208554
[TBL] [Abstract][Full Text] [Related]
7. Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas.
Oliva CR; Markert T; Gillespie GY; Griguer CE
Oncotarget; 2015 Feb; 6(6):4330-44. PubMed ID: 25726526
[TBL] [Abstract][Full Text] [Related]
8. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
[TBL] [Abstract][Full Text] [Related]
9. Loss of ATM impairs proliferation of neural stem cells through oxidative stress-mediated p38 MAPK signaling.
Kim J; Wong PK
Stem Cells; 2009 Aug; 27(8):1987-98. PubMed ID: 19544430
[TBL] [Abstract][Full Text] [Related]
10. Reactive Oxygen Species Induce Endothelial Differentiation of Liver Cancer Stem-Like Sphere Cells through the Activation of Akt/IKK Signaling Pathway.
Zhao Z; Gao J; Li C; Xu X; Hu Y; Huang S
Oxid Med Cell Longev; 2020; 2020():1621687. PubMed ID: 33101583
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
[TBL] [Abstract][Full Text] [Related]
12. Glutathione depletion in CYP2E1-expressing liver cells induces toxicity due to the activation of p38 mitogen-activated protein kinase and reduction of nuclear factor-kappaB DNA binding activity.
Wu D; Cederbaum A
Mol Pharmacol; 2004 Sep; 66(3):749-60. PubMed ID: 15322268
[TBL] [Abstract][Full Text] [Related]
13. Glutathione depletion activates mitogen-activated protein kinase (MAPK) pathways that display organ-specific responses and brain protection in mice.
Limón-Pacheco JH; Hernández NA; Fanjul-Moles ML; Gonsebatt ME
Free Radic Biol Med; 2007 Nov; 43(9):1335-47. PubMed ID: 17893047
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells.
Sato A; Okada M; Shibuya K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Kayama T; Kitanaka C
Stem Cell Res; 2013 Jul; 11(1):601-10. PubMed ID: 23651583
[TBL] [Abstract][Full Text] [Related]
15. Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells.
Beccafico S; Morozzi G; Marchetti MC; Riccardi C; Sidoni A; Donato R; Sorci G
Carcinogenesis; 2015 Sep; 36(9):1071-83. PubMed ID: 26153023
[TBL] [Abstract][Full Text] [Related]
16. PDGF-B Can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation.
Jiang Y; Boije M; Westermark B; Uhrbom L
Neoplasia; 2011 Jun; 13(6):492-503. PubMed ID: 21677873
[TBL] [Abstract][Full Text] [Related]
17. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
Liu H; Zhou BH; Qiu X; Wang HS; Zhang F; Fang R; Wang XF; Cai SH; Du J; Bu XZ
Free Radic Biol Med; 2012 Dec; 53(12):2204-17. PubMed ID: 23085518
[TBL] [Abstract][Full Text] [Related]
18. Human adipose tissue-derived multilineage progenitor cells exposed to oxidative stress induce neurite outgrowth in PC12 cells through p38 MAPK signaling.
Moriyama M; Moriyama H; Ueda A; Nishibata Y; Okura H; Ichinose A; Matsuyama A; Hayakawa T
BMC Cell Biol; 2012 Aug; 13():21. PubMed ID: 22870983
[TBL] [Abstract][Full Text] [Related]
19. FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity.
Sunayama J; Sato A; Matsuda K; Tachibana K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
Stem Cells; 2011 Sep; 29(9):1327-37. PubMed ID: 21793107
[TBL] [Abstract][Full Text] [Related]
20. Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells.
López-Valero I; Dávila D; González-Martínez J; Salvador-Tormo N; Lorente M; Saiz-Ladera C; Torres S; Gabicagogeascoa E; Hernández-Tiedra S; García-Taboada E; Mendiburu-Eliçabe M; Rodríguez-Fornés F; Sánchez-Domínguez R; Segovia JC; Sánchez-Gómez P; Matheu A; Sepúlveda JM; Velasco G
Theranostics; 2020; 10(11):5120-5136. PubMed ID: 32308772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
